Explained — What led to the nearly 10% fall in Cohance Lifesciences shares on Wednesday
Published on 29/10/2025 09:38 AM
Explained — What led to the nearly 10% fall in Cohance Lifesciences shares on WednesdayShares of Cohance Lifesciences fell as much as 10% in early trading on Wednesday, but are recovering from the lows, currently trading 6.4% lower at ₹804.8. The stock is down 28% from its recent 52-week high of ₹1,121, and has declined 25% on a year-to-date basis.By Hormaz Fatakia October 29, 2025, 9:38:34 AM IST (Published)1 Min ReadShares of Cohance Lifesciences Ltd. fell up to 10% on Wednesday, October 29, after the company informed the exchanges that V Prasada Raju, has quit as Managing Director and Director of the company. The resignation is effective from October 28 itself.
In his resignation letter, Prasada Raju cited a consideration of his personal priorities and to "continue his learning journey" as the reasons behind his resignation. He will continue till a smooth and orderly transition takes place.
Cohance Lifesciences has appointed Himanshu Agarwal as Additional Director and Whole-time Director from October 29, subject to approval from shareholders of the company. Agarwal is currently Chief Financial Officer (CFO), at Cohance.
Agarwal's term will be for a period of five years, Cohance said in its exchange filing. Agarwal has been CFO at Cohance since Janauary 2024.
Shares of Cohance Lifesciences fell as much as 10% in early trading on Wednesday, but are recovering from the lows, currently trading 6.4% lower at ₹804.8. The stock is down 28% from its recent 52-week high of ₹1,121, and has declined 25% on a year-to-date basis.Continue ReadingCheck out our in-depth Market Coverage, Business News & get real-time Stock Market Updates on CNBC-TV18. Also, Watch our channels CNBC-TV18, CNBC Awaaz and CNBC Bajar Live on-the-go!Tagscohanceshare market today